| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bertilimumab | small-inducible cytokine a11 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vision[MeSHID:D014785] Allergic Reaction[MeSHID:D006967] Ulcerative Colitis[MeSHID:D003093] Psoriasis[MeSHID:D011565] Bullous pemphigoid[MeSHID:D010391] Eye[MeSHID:D005123] |
42.43 | phase 2 | inhibitor |
| bertilimumab | small-inducible cytokine a11 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vision[MeSHID:D014785] Allergic Reaction[MeSHID:D006967] Ulcerative Colitis[MeSHID:D003093] Psoriasis[MeSHID:D011565] Bullous pemphigoid[MeSHID:D010391] Eye[MeSHID:D005123] |
42.43 | phase 2 | unknown |
| click here to return to the previous page | ||||||||